Eli Lilly to set up four manufacturing facilities in US for $27 billion
Eli Lilly will set up four new pharmaceutical manufacturing facilities in the US for $27 billion to further bolster its supply chains, according.
Drugs
Medical
Pharma
Health
Medical
Research
Columbia engineers make robots that learn by watching themselves
Robots can teach themselves how to move by watching their motions through a camera, similar to looking at a mirror, and also overcome.
Drugs
Health
Medical
WHO Foundation to crowdsource funds for global health programmes
The World Health Organization is crowdsourcing to fund its health programs by urging individuals globally to donate to the ‘1 Dollar 1 World.
Drugs
Health
Medical
Unknown illness sweeps across Congo’s northwest, 53 people die
A mystery illness sweeping over Congo has killed 53 people and infected 400 more, with an initial probe tracking the outbreak to three.
Health
Medical
Research
UK researchers develop AI tool to detect brain lesions in epileptic children
King’s and University College of London researchers have developed an artificial intelligence tool that can detect 64% of brain abnormalities, that radiologists miss,.
Drugs
Health
Medical
Regeneron’s trial therapy improves hearing in children with gene mutations
Regeneron Pharmaceuticals, Inc.’s investigational gene therapy improved hearing in 10 out of 11 children born with hearing loss because of gene mutation, according.
Health
Medical
Pharma
Medtronic Plc’s neurostimulator for Parkinson’s gets USFDA approval
Ireland’s Medtronic Plc’s deep brain stimulation device for patients with Parkinson’s disease has been approved by the US Food and Drug Administration, according.
Health
Medical
Pharma
Saudi Arabia reaffirms $500 million pledge to eradicate polio
Saudi Arabia has reaffirmed a $500 million pledge to the WHO’s Global Polio Eradication Initiative to fight the disease plaguing vulnerable children, according.
Health
Medical
Pharma
KKR to acquire majority stake in India’s HCG for $400 million
US-based private equity and advisory investment firm KKR & Co. Inc. will pay CVC Capital Partners $400 million to acquire a majority stake.
Drugs
Health
Medical
US regulator clears Mirum’s oral drug for reducing cholesterol deposits
Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.